NCT01226095

Evaluation of the Effectiveness, Compliance of Ibuprofen in a Sustained Release Form in the Treatment of Egyptian Osteoarthritic Patients

A Prospective, Multi-center, Post-marketing Observational Study to Evaluate the Effectiveness and Compliance of Ibuprofen in a Sustained Release Form in the Treatment of Egyptian Osteoarthritic Patients

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 519 (actual)
• Sponsor: Abbott · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This is a prospective, multi-center, post-marketing observational study to evaluate the effectiveness and compliance of ibuprofen in a sustained release form in the treatment of Egyptian osteoarthritic patients.

Detailed description

This was a prospective, longitudinal, multicenter observational study conducted in a clinical practice setting where the study product was used in osteoarthritis patients as indicated in the approved package insert; the dosing regimen of Brufen retard is 2 tablets as a single dose once daily.

Conditions

• Osteoarthritis
• Pain
• Morning Stiffness

Timeline

• Start date: 2010-06-01
• Primary completion: 2010-11-01
• Completion: 2010-11-01
• First posted: 2010-10-21
• Last updated: 2013-09-20
• Results posted: 2012-01-23

Locations

15 sites across 1 country: Egypt